Hirtle Callaghan & CO LLC Pfizer Inc Transaction History

Hirtle Callaghan & CO LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $1.31 Million - $1.43 Million	-34,800 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$33.26 - $35.29 $63,327 - $67,192	-1,904 Reduced 5.19%	34,800 $1.26 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.14 Million - $1.25 Million	36,704	36,704 $1.31 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.